Oncology drug development presents one of the most demanding environments for pharmacovigilance, with high case volumes, complex safety profiles, and multi regional regulatory expectations. Organizations require experienced partners to establish integrated and compliant PV systems.
AWINSA was engaged by a biotechnology company to address fragmented pharmacovigilance processes and regulatory challenges across multiple oncology programs. This case study highlights how AWINSA’s structured approach helped centralize operations, enhance safety oversight, and ensure global compliance.
Copyright © 2024 AWINSA Life Sciences Pvt. Ltd. All rights reserved.
59 E,Shrewsbury Place
Princeton, NJ 08540
United States
E13/9 First floor, Vasant Vihar,
New Delhi 110057
Wilhelmina Druckerlaan 10,
6532 SR,
Nijmegen,
The Netherlands
Cerrada Ahuizotla 53,
Col. Santiago Ahuizotla,
Del. Azcapotzalco
CP.02750
Ciudad de México, México.
